Global Whole Exome Sequencing Market 2023
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
$2,600.00
The global high content screening market was valued at USD 1,105 million in 2021 to USD 2,046 million by 2028, progressing at a CAGR of 9.2% from 2022 to 2028, according to Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global high content screening market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the high content screening industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, application, end user, and region. The global market for high content screening can be segmented by component: consumables (reagents and kits), instrument or platform, services, software and analytics. In 2021, the instrument or platform segment made up the largest share of revenue generated by the high content screening market. High content screening market is further segmented by application: compound profiling, drug discovery, molecular diagnosis, oncology, toxicity studies, others. The drug discovery segment was the largest contributor to the global high content screening market in 2021. Based on end user, the high content screening market is segmented into: academic institutions, laboratories and pathology centers, pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the global high content screening market. On the basis of region, the high content screening market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By component:
– consumables (reagents and kits)
– instrument or platform
– services
– software and analytics
By application:
– compound profiling
– drug discovery
– molecular diagnosis
– oncology
– toxicity studies
– others
By end user:
– academic institutions
– laboratories and pathology centers
– pharmaceutical and biotechnology companies
By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The instrument market is further segmented into cytometers, detectors and sensors, imaging devices, liquid handling instruments, plate readers, others. Among these, the imaging devices segment was accounted for the highest revenue generator in 2021.
The report explores the recent developments and profiles of key vendors in the Global High Content Screening Market, including Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Danaher Corp., GE Healthcare, Merck KGaA, Olympus Corporation, PerkinElmer, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Yokogawa Electric Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global high content screening market.
– To classify and forecast the global high content screening market based on component, application, end user, region.
– To identify drivers and challenges for the global high content screening market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global high content screening market.
– To identify and analyze the profile of leading players operating in the global high content screening market.
Why Choose This Report
– Gain a reliable outlook of the global high content screening market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY COMPONENT
· Consumables (reagents and kits)
· Instrument or platform
· Services
· Software and analytics
PART 6. MARKET BREAKDOWN BY APPLICATION
· Compound profiling
· Drug discovery
· Molecular diagnosis
· Oncology
· Toxicity studies
· Others
PART 7. MARKET BREAKDOWN BY END USER
· Academic institutions
· Laboratories and pathology centers
· Pharmaceutical and biotechnology companies
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 9. KEY COMPANIES
· Agilent Technologies Inc.
· Bio-Rad Laboratories, Inc.
· Danaher Corp.
· GE Healthcare
· Merck KGaA
· Olympus Corporation
· PerkinElmer, Inc.
· Sartorius AG
· Thermo Fisher Scientific Inc.
· Yokogawa Electric Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Agilent Technologies Inc.
Bio-Rad Laboratories, Inc.
Danaher Corp.
GE Healthcare
Merck KGaA
Olympus Corporation
PerkinElmer, Inc.
Sartorius AG
Thermo Fisher Scientific Inc.
Yokogawa Electric Corporation
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2021 |
Forecast Year | 2022-2028 |
CAGR (2022-2028) | 9.2% |
Pages | 88 |
Key Players | Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corp., GE Healthcare, Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sartorius AG, Thermo Fisher Scientific Inc., Yokogawa Electric Corporation |
According to the latest estimates, the global whole exome sequencing market is predicted to be growing at a CAGR of over 14.2% from 2023 to 2029. The top market companies…
The global continuous bioprocessing market, in terms of revenue, is expected to grow by 17.9 percent annually through 2029, according to the latest estimates. The top market companies profiles included…
The global virology testing market is projected to expand at a CAGR of ~1.2 percent across the forecast period of 2023 – 2029, according to the latest edition of the…
Please fill out our form and we will get back to you.